-+ 0.00%
-+ 0.00%
-+ 0.00%

Lake Street Maintains Buy on OptimizeRx, Lowers Price Target to $20

Benzinga·03/06/2026 20:42:53
Listen to the news
Lake Street analyst Eric Martinuzzi maintains OptimizeRx (NASDAQ:OPRX) with a Buy and lowers the price target from $24 to $20.